BioSpace News Archive

Drug Development

Active Ingredient of Marijuana May Help With Alzheimer’s … at Least If You’re a Mouse

The mice had been genetically modified to have symptoms similar to Alzheimer’s. They were given a synthetic version of tetrahydrocannabinol (THC) for six weeks. In their study, the mice receiving the THC performed as well on a memory test as the healthy mice.

November 8, 2018
·
2 min read
·
Mark Terry
BioMidwest

Updated: Amgen Co-Founds Fund to Help Conejo Valley Shooting Victims; Donates to Wildfire Victims

The fund will be administered through the Ventura County Community Foundation. Officials indicate that 100 percent of the funds will go to help victims’ families. The Foundation is calling for additional donations.

November 8, 2018
·
3 min read
·
Mark Terry
Business

BioArctic Interim Report January - September 2018

BioArctic reports strong BAN2401 Phase 2b results for Alzheimer patients.

November 8, 2018
·
8 min read
Job Trends

Marker Therapeutics to Present at Three Upcoming November 2018 Healthcare Conferences

Marker Therapeutics, Inc. today announced that its President and CEO, Peter L. Hoang, will participate in three upcoming healthcare conferences.

November 8, 2018
·
4 min read
Business

Sesen Bio Reports Third Quarter 2018 Financial Results and Planned VISTA Trial Readouts

Company Expects to Report Six-Month Update from VISTA Trial in December 2018; On-Track to Report 12-Month VISTA Trial Data in Mid-2019

November 8, 2018
·
7 min read
Policy

Mallinckrodt Earns International Standard ISO 13485:2016 and Medical Device Single Audit Program (MDSAP) Certifications for INOmax® DSIR® Plus Nitric Oxide Delivery Systems

Achievements Indicate Mallinckrodt Meets Standards and Regulations Among the Most Comprehensive for Medical Device Quality Management Systems

November 8, 2018
·
10 min read
Drug Development

Evofem Biosciences Completes Phase 3 Clinical Trial of Amphora for Prevention of Pregnancy

Company Remains on Track for AMPOWER Top-line Results in Late 2018

November 8, 2018
·
7 min read
Policy

Centene Subsidiary Earns NCQA Distinction

Centene Corporation today announced that its wholly-owned Texas subsidiary, Superior HealthPlan, has earned a Long Term Services and Supports (LTSS) distinction from the National Committee for Quality Assurance (NCQA).

November 8, 2018
·
9 min read
Business

Sinovac Reports Unaudited First Half of 2018 Financial Results

Sinovac Biotech Ltd. announced today its unaudited financial results for the six months ended June 30, 2018.

November 8, 2018
·
15 min read
Business

Biostage Reports 2018 Third Quarter Financial Results

- Scientific feedback along with new and consistent data continue to validate technology

November 8, 2018
·
9 min read